10 posts published
Sub-Cellular Spatial Transcriptomics & Single-Cell RNA Sequencing: Mapping the 3D Tumor Microenvironment at Nanometer Resolution Last updated: August 15, 2026 | 13-minute read Executive Summary: Tradi…
Universal Off-the-Shelf Allogeneic CAR-T Cells: Multiplex CRISPR Knockouts of TRAC and B2M Eliminate GVHD & Immune Rejection Last updated: August 11, 2026 | 13-minute read Executive Summary: First-gen…
Mitochondrial DNA Base Editing In Vivo: DddA-Derived Cytosine Deaminases (DdCBE) for Leber's Hereditary Optic Neuropathy Last updated: August 07, 2026 | 13-minute read Executive Summary: For decades, …
Clinical Whole Genome Sequencing & Polygenic Risk Scores (PRS): Early Detection of Coronary Artery Disease & Familial Hypercholesterolemia Last updated: August 02, 2026 | 13-minute read Executive Summ…
Synthetic Human Embryo Models (Stembryos): Stem-Cell-Derived Gastruloids & 3D Organogenesis in Post-Implantation Biology Last updated: July 27, 2026 | 13-minute read Executive Summary: The second to f…
CRISPR-Cas12a & Cas13 Systems: Collateral Cleavage Mechanisms in Ultra-Rapid Viral Diagnostics & Targeted RNA Therapeutics Last updated: July 22, 2026 | 13-minute read Executive Summary: Beyond standa…
Modified TERT mRNA Telomere Extension: Reversing Cellular Senescence and Expanding Proliferative Capacity in Human Primary Cells Last updated: July 16, 2026 | 13-minute read Executive Summary: Telomer…
In Vivo Epigenetic Reprogramming: Yamanaka OSK Factors Reset Biological Age & Restore Vision in Glaucoma Clinical Trials Last updated: July 08, 2026 | 13-minute read Executive Summary: In 2006, Shinya…
Prime Editing In Vivo: Search-and-Replace Genomic Rewriting for Complex Monogenic Disorders in Human Clinical Trials Last updated: July 02, 2026 | 13-minute read Executive Summary: While traditional C…
In Vivo Base Editing in Humans: Landmark NEJM Trial of VERVE-102 Durably Lowers Cholesterol Published in The New England Journal of Medicine on May 25, 2026, the Phase 1b clinical trial of VERVE-102 d…
